Bioceltix S.a.
BCX
Rank in Stocks
#19653
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The companyโs products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$17.22
Last synced: 2026-11-16
Market Cap
$95.26M
Change (1 day)
-2.06%
Change (1 year)
-30.27%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Bioceltix S.a. (BCX)
Category
Healthcare
Operating Margin for Bioceltix S.a. (BCX)
Operating Margin as of November 2026 TTM: 0.00%
According to Bioceltix S.a.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Bioceltix S.a. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -36,934.63% | -85.33% |
| 2019 | -251,764.00% | 1,106.64% |
| 2018 | -20,864.88% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 33.87% | - |
US
|
|
| -116.04% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioceltix S.a.'s operating margin
What was Bioceltix S.a.'s operating margin in 2025?
In 2025, Bioceltix S.a.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Bioceltix S.a.'s operating margin changed since 2020?
From 2020 to 2025, Bioceltix S.a.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-36,934.63%).
How does Bioceltix S.a.'s operating margin compare with similar companies?
Bioceltix S.a.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.